Evidence map›Paper›PMID 39772198›Full record

ArticleViruses2024

Seasonal Shifts in Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses After the COVID-19 Pandemic: An Eight-Year Retrospective Study in Jalisco, Mexico.

Ernestina Quintero-Salgado, Jaime Briseno-Ramírez, Gabriel Vega-Cornejo, Roberto Damian-Negrete, Gustavo Rosales-Chavez, Judith Carolina De Arcos-Jiménez

Abstract read
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Shifts in epidemic patterns and age dynamics of RSV, IFV, and SARS-CoV-2 in Chinese children following COVID-19 non-pharmaceutical intervention relaxation, 2017 - 2024.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ernestina Quintero-SalgadoState Public Health Laboratory, Zapopan 45170, Jalisco, Mexico.
Jaime Briseno-RamírezHealth Division, Tlajomulco University Center, University of Guadalajara, Tlajomulco de Zuñiga 45641, Jalisco, Mexico.ORCID 0009-0006-1901-392X
Gabriel Vega-CornejoHealth Division, Tlajomulco University Center, University of Guadalajara, Tlajomulco de Zuñiga 45641, Jalisco, Mexico.
Roberto Damian-NegreteHealth Division, Tlajomulco University Center, University of Guadalajara, Tlajomulco de Zuñiga 45641, Jalisco, Mexico.
Gustavo Rosales-ChavezHealth Division, Tlajomulco University Center, University of Guadalajara, Tlajomulco de Zuñiga 45641, Jalisco, Mexico.
Judith Carolina De Arcos-JiménezState Public Health Laboratory, Zapopan 45170, Jalisco, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic profoundly disrupted the epidemiology of respiratory viruses, driven primarily by widespread non-pharmaceutical interventions (NPIs) such as social distancing and masking. This eight-year retrospective study examines the seasonal patterns and incidence of influenza virus, respiratory syncytial virus (RSV), and other respiratory viruses across pre-pandemic, pandemic, and post-pandemic phases in Jalisco, Mexico. Weekly case counts were analyzed using an interrupted time series (ITS) model, segmenting the timeline into these three distinct phases. Significant reductions in respiratory virus circulation were observed during the pandemic, followed by atypical resurgences as NPIs were relaxed. Influenza displayed alternating subtype dominance, with influenza A H3 prevailing in 2022, influenza B surging in 2023, and influenza A H1N1 increasing thereafter, reflecting potential immunity gaps. RSV activity was marked by earlier onset and higher intensity post-pandemic. Other viruses, including human rhinovirus/enterovirus (HRV/HEV) and parainfluenza virus (HPIV), showed altered dynamics, with some failing to return to pre-pandemic seasonality. These findings underscore the need for adaptive surveillance systems and vaccination strategies to address evolving viral patterns. Future research should investigate the long-term public health implications, focusing on vaccination, clinical outcomes, and healthcare preparedness.

Indexed as

COVID-19Influenza, HumanRespiratory Syncytial Virus InfectionsSeasonsHumansIncidenceInfluenza A Virus, H1N1 SubtypeMexicoPandemicsRespiratory Syncytial Virus, HumanRespiratory Tract InfectionsRetrospective StudiesSARS-CoV-2COVID-19 impactinfluenza seasonalityinterrupted time series analysisrespiratory infectionsrespiratory viruses’ trendsvirus resurgencevirus seasonality

Identifiers

PMID39772198
PMCPMC11680140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.